Table 1.

Nominal, peak and time-weighted average (TWA) concentrations (μg/L) of azoxystrobin during the treatment periods (days 0–42)

Treatment exposure regimes	Intended conc. (μg/L)	Nominal initial conc. (μg/L)	% of nominal initial conc. (%)	Measured peak conc. (4-h after application) (μg/L)	% of measured peak conc. (%)	TWA (0–42 days) (μg/L)	% of TWA conc. (%)
CAT10	10	11.7	117	12.9	129	9.35	93.5
CAT33	33	37.1	112	41.9	127	32.8	99.3
SAT33	33	32.8	104	38.1	121	14.9
FAT16	15.8	15.7	99.3	18.4	121	14.7

Nominal initial concentrations are based on the concentrations measured in treatment solutions

All concentrations are presented as means of three replicates